Synopsys, Inc. (SNPS) Misses Q2 EPS by 2c; Issues Confident Q3 Outlook; Guides FY12
Tweet
Share
E-mailGet Alerts SNPS Hot Sheet
Price: $456.60 +0.24%
Revenue Growth %: +40.2%
Financial Fact:
General and administrative: 42.16M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +40.2%
Financial Fact:
General and administrative: 42.16M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Synopsys, Inc. (NASDAQ: SNPS) reported Q2 EPS of $0.53, $0.02 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $432.6 million versus the consensus estimate of $417.26 million.
Synopsys, Inc. sees Q3 2012 EPS of $0.49-$0.51, versus the consensus of $0.46. Synopsys, Inc. sees Q3 2012 revenue of $440-$448 million, versus the consensus of $412.47 million.
Synopsys, Inc. sees FY2012 EPS of $2.03-$2.07, versus the consensus of $2.03. Synopsys, Inc. sees FY2012 revenue of $1.74-$1.76 billion, versus the consensus of $1.67 billion.
For earnings history and earnings-related data on Synopsys, Inc. (SNPS) click here.
Synopsys, Inc. sees Q3 2012 EPS of $0.49-$0.51, versus the consensus of $0.46. Synopsys, Inc. sees Q3 2012 revenue of $440-$448 million, versus the consensus of $412.47 million.
Synopsys, Inc. sees FY2012 EPS of $2.03-$2.07, versus the consensus of $2.03. Synopsys, Inc. sees FY2012 revenue of $1.74-$1.76 billion, versus the consensus of $1.67 billion.
For earnings history and earnings-related data on Synopsys, Inc. (SNPS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Ennis (EBF) Reports In-Line Q1 EPS
- Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
